查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1680761

头颈癌诊断全球市场报告：趋势、预测与竞争分析（至 2031 年）

Head and Neck Cancer Diagnostic Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球头颈癌诊断市场前景光明，医院、门诊手术中心和诊断中心市场都存在机会。预计到 2031 年全球头颈癌诊断市场规模将达到 34 亿美元，2025-2031 年期间的复合年增长率为 7.1%。这个市场的主要驱动力是头颈癌盛行率的不断上升、医疗保健服务的改善以及人们对头颈癌的体征和症状以及早期发现的重要性的认识不断提高。

  • Lucintel 预测，基于诊断，影像将在预测期内经历最高的成长。
  • 根据最终用途，医院可能继续成为最大的细分市场，因为它们具有更好的疾病诊断能力，并配备了最新的医疗设备和技术，可以为患者提供最佳的治疗。
  • 从地区来看，北美预计将在预测期内继续保持最大地区地位，因为该地区拥有强大的医疗保健基础设施、优惠的报销政策、对疾病的高度认识以及政府对医疗保健行业发展的支持。

头颈癌诊断市场的策略性成长机会

头颈癌诊断市场在多种应用领域提供了多种成长机会。了解这些机会将有助于相关人员选择投资和发展的领域。

  • 分子诊断：对分子诊断测试日益增长的需求为市场创造了巨大的机会。这些测试可以早期发现和分类头颈癌，提供有效治疗所需的重要资讯。
  • 人工智慧增强成像解决方案：医疗保健专业人员需要人工智慧增强成像解决方案来提高诊断准确性。这些技术具有巨大的潜力，可以开发和推广，以提高诊断效率和患者管理。
  • 液态切片应用：液态切片液态生物检体的日益广泛使用将推动收益成长。用于早期诊断和治疗评估的非侵入性测试正在迅速涌现，使患者和医疗服务提供者都受益。
  • 与远端医疗的整合：远端医疗整合透过远距提供诊断服务提供了真正的成长机会。扩大远距离诊断工具市场可以改善患者照护，尤其是在偏远地区。
  • 致力于合作研究：学术和临床研究机构之间的合作促进了可销售的诊断工具和技术的快速发展。这些倡议将有助于企业在市场上更具竞争力。

这些策略性成长机会解决了头颈癌诊断市场中新出现的空白，使相关人员能够培养创新解决方案，增强病患管理和市场竞争力。

头颈癌诊断市场驱动因素与挑战

推动市场发展的因素包括诊断技术的进步、公众对癌症筛检和治疗的认识不断提高以及医疗保健预算的增加。挑战包括监管障碍、昂贵的诊断方法以及某些地区某些技术的短缺。

头颈癌诊断市场受以下因素驱动：

  • 技术进步：诊断服务市场正在随着成熟和新兴的分子测试的不断进步而不断发展。这些发展提高了头颈癌诊断的效率和及时性，从而增加了对诊断程序的需求。
  • 扩大癌症教育的覆盖范围：公共卫生宣传活动正在提高人们对癌症（包括头颈癌）早期发现的认识。这使得更多的人接受筛检和诊断。
  • 医疗保健支出增加：新兴市场的医疗保健支出正在增加，从而可以投资于诊断工具。这些市场的医疗机构正在引进新的诊断设备，改善优质医疗服务，推动市场成长。
  • 老年人口不断增加：人口老化导致头颈癌发生率不断上升。老年人口的成长推动了对诊断服务的需求，进一步推动了市场成长。
  • 标靶治疗方案：随着更多标靶治疗的开发，对与这些疗法相符的先进诊断工具的需求也日益增加。根据患者独特的健康状况来诊断癌症增加了对客製化诊断工具的需求。

头颈癌诊断市场面临的挑战如下：

  • 昂贵的先进诊断工具：新的诊断设备通常价格昂贵，限制了其在资源贫乏地区的使用。这可能会导致诊断、治疗和復原的延迟。
  • 监理合规挑战：对于公司来说，遵守诊断市场的复杂法规可能是一项艰鉅的任务。遵守各种标准和法律的成本可能很高，并且会减缓新产品进入市场的速度。
  • 获得先进诊断技术的机会有限：许多地区​​，特别是发展中国家，获得先进诊断技术的机会有限。这会导致早期检测率降低和护理品质差，需要采取适当的解决方案。

头颈癌诊断市场受到驱动因素和挑战的影响。了解这些因素对于相关人员提供满足市场需求并利用成长机会的解决方案至关重要。

目录

第一章执行摘要

第二章全球头颈癌诊断市场：市场动态

  • 简介、背景和分类
  • 供应链
  • 产业驱动力与挑战

第三章市场趋势与预测分析（2019-2031）

  • 宏观经济趋势（2019-2024）及预测（2025-2031）
  • 全球头颈癌诊断市场趋势（2019-2024）及预测（2025-2031）
  • 全球头颈癌诊断市场（按类型）
    • 喉癌
    • 咽癌
    • 唾液腺癌
    • 唇癌和口腔癌
    • 鼻咽癌
    • 其他的
  • 全球头颈癌诊断市场（按诊断）
    • 切片筛检测试
    • 血液检查
    • 牙科诊断
    • 影像学诊断
    • 内视镜检查
  • 全球头颈癌诊断市场（按疗法）
    • 化疗
    • 放射治疗
    • 标靶治疗
    • 外科手术
    • 其他的
  • 全球头颈癌诊断市场（依最终用途）
    • 医院
    • 门诊手术中心
    • 诊断中心
    • 其他的

第四章。各地区市场趋势及预测分析（2019-2031）

  • 全球头颈癌诊断市场（按地区）
  • 北美头颈癌诊断市场
  • 欧洲头颈癌诊断市场
  • 亚太地区头颈癌诊断市场
  • 世界其他地区头颈癌诊断市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 全球头颈癌诊断市场成长机会（按类型）
    • 全球头颈癌诊断市场的成长机会（按诊断）
    • 全球头颈癌诊断市场的成长机会（按疗法）
    • 全球头颈癌诊断市场的成长机会（以最终用途）
    • 全球头颈癌诊断市场各区域成长机会
  • 全球头颈癌诊断市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球头颈癌诊断市场的产能扩张
    • 全球头颈癌诊断市场的合併、收购与合资企业
    • 认证和许可

第七章主要企业简介

  • GE Healthcare
  • Philips
  • Siemens Healthineers
  • Merck
  • Eli Lilly
简介目录

The future of the global head and neck cancer diagnostic market looks promising with opportunities in the hospital, ambulatory surgical center, and diagnostic center markets. The global head and neck cancer diagnostic market is expected to reach an estimated 3.4 billion by 2031 with a CAGR of 7.1% from 2025 to 2031. The major drivers for this market are the increasing prevalence of head and neck cancer, surfing access to healthcare, and growing awareness of the signs and symptoms of head and neck cancer, as well as the importance of early detection.

  • Lucintel forecasts that, within the diagnosis category, imaging is expected to witness the highest growth over the forecast period.
  • Within the end use category, hospitals will remain the largest segment because it has better disease diagnosis capabilities and also has the latest medical equipment and technology, which allows them to provide patients with the best possible care.
  • In terms of regions, North America will remain the largest region during the forecast period due to the presence of a strong healthcare infrastructure, favorable reimbursement policies, high awareness about the disease, and government support for the development of the healthcare sector.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market is changing rapidly, and there are trends that will determine its future. These trends involve new ways of diagnosing and managing patients, as well as new treatment options.

  • Liquid Biopsy Development: Head and neck cancers may be diagnosed at an earlier stage when biopsies are not compatible with surgery. Liquid biopsies are becoming an accepted method of non-invasive tumor identification. They evaluate tumor cells in the bloodstream, providing both diagnosis and responses to treatment sooner than otherwise possible. This phenomenon is changing modern oncology by providing real-time information about tumor growth and response to therapy.
  • Artificial Intelligence in Diagnostics: There is a growing trend towards enhancing head and neck cancer diagnostics through artificial intelligence and machine learning. AI algorithms can assist individuals without prior training to review CT or MR imaging studies and analyze clinical data, thus enhancing clinical decision-making. This technology improves accuracy and efficiency in analyzing images, which are often time-consuming.
  • Personalization of Medicine Gaining Momentum: The increasing use of personalized medicine is driving a new trend toward personalized diagnostics and treatment methods. Genetic and molecular profiling helps determine distinct biomarkers for head and neck cancers, enabling targeted treatment that is more effective and less harmful.
  • Telemedicine and Remote Diagnostic Interfaces: The use of telemedicine for diagnosing head and neck cancers is increasing, particularly in rural and underserved areas. Patients can be treated remotely by monitoring their symptoms and providing timely interventions, which alleviates the burden on healthcare facilities. This expansion helps with early diagnosis of cancers.
  • Growing Cooperation between Academia and Industry: The collaboration between research centers and companies is becoming more active, with the goal of improving head and neck cancer diagnosis. These partnerships aim to foster the invention of better diagnostic tools, benefiting both the healthcare sector and the business environment.

Such trends are likely to positively affect the head and neck cancer diagnostic market by spurring new solutions, increasing diagnostic accuracy, and enabling individualized treatment. Shortly, the integration of new technologies and collaborations is expected to improve clinical outcomes and transform cancer care.

Recent Developments in the Head and Neck Cancer Diagnostic Market

The market for head and neck cancer diagnosis has undergone significant changes, leading to improved detection, accuracy, and patient management. Notable changes include technological advancements, regulatory approvals, and research collaborations.

  • Regulatory Approvals for Biomarkers: The recent FDA approvals of new biomarkers for head and neck cancers are promoting the diagnosis of these cancers. These tests are useful not only for tumor identification but also for assessing specific tumor features, aiding in the early administration of appropriate treatments, and improving clinical outcomes.
  • Imaging Technologies Upgrading: Advanced imaging technologies, such as 3D imaging and hybrid PET/CT scans, are now part of routine diagnostic practice, enabling precise diagnosis of head and neck cancers. These technologies improve treatment planning and monitoring for patients with head and neck tumors.
  • Designing Liquid Biopsies: Liquid biopsy test kits have revolutionized the prospects of diagnosing head and neck tumors. They allow for earlier cancer detection and enable treatment response assessments through simple blood tests instead of invasive procedures.
  • The Role of AI in Cancer Diagnosis: The application of artificial intelligence in imaging interpretation is increasing. AI algorithms can process vast amounts of imaging data with high accuracy, spotting tumors and minimizing human error, thus enhancing diagnostic effectiveness.
  • Telehealth Services: Telehealth services are improving access to diagnostic consultations, especially in rural areas. This approach provides efficient care, reducing the need for patients to visit healthcare facilities.

These trends are transforming the head and neck cancer diagnostic market by enhancing diagnostic accuracy, expanding access to cancer treatment, and enabling customized therapies. Over time, technological advancements are expected to further improve patient outcomes.

Strategic Growth Opportunities for Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market offers various growth opportunities across multiple applications. Understanding these opportunities helps stakeholders choose areas for investment and development.

  • Molecular Diagnostics: The growing demand for molecular diagnostic tests offers a significant opportunity in the market. These tests enable early detection and classification of head and neck cancers, providing critical information needed for effective treatment.
  • AI-Enhanced Imaging Solutions: Healthcare professionals require AI-enhanced imaging solutions that improve diagnostic accuracy. These technologies have high potential and can be developed and marketed to enhance diagnostic efficiency and patient management.
  • Liquid Biopsy Applications: Expanding the use of liquid biopsy applications can drive revenue growth. Non-invasive tests for early-stage diagnosis and treatment evaluation are rapidly emerging, benefiting both patients and service providers.
  • Telehealth Integration: The integration of telehealth offers an authentic growth opportunity by providing diagnostic services remotely. Expanding the market for remote diagnostic tools can improve patient care, especially in distant locations.
  • Initiatives for Collaborative Research: Collaboration between academic and clinical research institutions can lead to faster development of marketable diagnostic tools and techniques. These initiatives can help companies become more competitive in the market.

These strategic growth opportunities address emerging gaps in the head and neck cancer diagnostic market, allowing stakeholders to foster innovative solutions that enhance patient management and competitiveness.

Head and Neck Cancer Diagnostic Market Driver and Challenges

The major drivers in the market include advancements in diagnostic technology, increasing public awareness of cancer screening and treatment, and higher healthcare budgets. Challenges include regulatory hurdles, expensive diagnostic methods, and the lack of certain technologies in some regions.

The factors driving the head and neck cancer diagnostic market include:

  • Technological Advancements: The diagnostic services market is evolving with continuous advancements in both established and emerging molecular-based tests. These developments improve the efficiency and timing of head and neck cancer diagnoses, leading to increased demand for diagnostic procedures.
  • Expanding the Scope of Cancer Education: Public health campaigns have increased awareness about the early detection of cancers, including head and neck cancer. This is encouraging more people to undergo screenings and diagnostics.
  • Increasing Healthcare Spending: Emerging markets are increasing healthcare spending, enabling investments in diagnostic tools. Healthcare institutions in these markets are acquiring new diagnostic equipment, improving access to quality healthcare, and facilitating market growth.
  • Geriatric Population: The aging population is contributing to a rise in head and neck cancer prevalence. As the elderly population grows, the demand for diagnostic services increases, further driving market growth.
  • Targeted Therapy Programs: As more targeted therapies are developed, the demand for advanced diagnostic tools that match these therapies is increasing. Diagnosing cancers based on each patient's specific health condition will drive the need for tailored diagnostic tools.

Challenges in the head and neck cancer diagnostic market include:

  • Advanced Diagnostic Tools are Costly: New diagnostic devices are often expensive, limiting their use in resource-poor areas. This can result in delays in diagnosis and treatment, leading to poorer recovery outcomes.
  • Challenges Associated with Regulatory Compliance: Navigating complex regulations in the diagnostic market can be daunting for companies. Compliance with various standards and laws can be costly and delay the market entry of new products.
  • Limited Reach to Advanced Diagnostic Technologies: Access to advanced diagnostic technology is limited in many areas, particularly in developing countries. This can result in lower early detection rates and reduced care quality, which needs to be addressed through relevant solutions.

The head and neck cancer diagnostic market is shaped by both enablers and obstacles. Understanding these factors is crucial for stakeholders to offer solutions that meet market needs while taking advantage of growth opportunities.

List of Head and Neck Cancer Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies head and neck cancer diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the head and neck cancer diagnostic companies profiled in this report include-

  • GE Healthcare
  • Philips
  • Siemens Healthineers
  • Merck
  • Eli Lilly

Head and Neck Cancer Diagnostic by Segment

The study includes a forecast for the global head and neck cancer diagnostic market by type, diagnosis, treatment, end use, and region.

Head and Neck Cancer Diagnostic Market by Type [Analysis by Value from 2019 to 2031]:

  • Laryngeal Cancer
  • Pharyngeal Cancer
  • Salivary Gland Cancer
  • Lip & Oral Cavity Cancer
  • Nasopharyngeal Cancer
  • Others

Head and Neck Cancer Diagnostic Market by Diagnosis [Analysis by Value from 2019 to 2031]:

  • Bioscopy Screening Tests
  • Blood Tests
  • Dental Diagnosis
  • Imaging
  • Endoscopy

Head and Neck Cancer Diagnostic Market by Treatment [Analysis by Value from 2019 to 2031]:

  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Surgery
  • Others

Head and Neck Cancer Diagnostic Market by End Use [Analysis by Value from 2019 to 2031]:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

Head and Neck Cancer Diagnostic Market by Region [Analysis by Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Head and Neck Cancer Diagnostic Market

The head and neck cancer diagnostic market is making significant progress due to technological advancements, rising demand for cancer diagnosis, and increased awareness about early detection. The United States, China, Germany, India, and Japan are investing in R&D to advance diagnostic techniques for head and neck cancer. These developments aim to improve healthcare quality by enhancing diagnostic accuracy, reducing costs, and enabling timely action.

  • United States: Advances in molecular diagnosis and liquid biopsy strategies are revolutionizing the diagnosis of head and neck cancer. The development of targeted therapies and improvements in diagnostic imaging technologies, such as artificial intelligence, are also enhancing diagnostic accuracy and efficiency.
  • China: China's growing healthcare investment is driving innovations in cancer diagnosis, particularly for head and neck cancers. New imaging devices, such as advanced CT scanners, are being adopted, and there is a strong focus on the development of genetic testing kits for screening cancer susceptibility.
  • Germany: Germany is making significant strides in creating accurate diagnostic tools for head and neck cancers. New research emphasizes the use of directed imaging radionics to increase sensitivity to early tumor changes, while collaborative efforts between universities and healthcare companies are developing innovative biopsy techniques.
  • India: Efforts in India are focused on improving the accessibility of head and neck cancer diagnostic services, especially in rural areas. Initiatives such as telemedicine and mobile health services aim to improve access, while cost-effective diagnostic studies are being conducted to create affordable screening tests.
  • Japan: Japan is at the forefront of head and neck cancer management, with advanced imaging systems incorporated into diagnostic practices. Combined imaging modalities like PET-CT are improving diagnostic efficacy, while targeted therapy development based on cancer genomics is enhancing personalized medicine in the country.

Features of the Global Head and Neck Cancer Diagnostic Market

Market Size Estimates: Head and neck cancer diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Head and neck cancer diagnostic market size by various segments, such as by type, diagnosis, treatment, end use, and region in terms of ($B).

Regional Analysis: Head and neck cancer diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, diagnosis, treatments, end uses, and regions for the head and neck cancer diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the head and neck cancer diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the head and neck cancer diagnostic market by type (laryngeal cancer, pharyngeal cancer, salivary gland cancer, lip & oral cavity cancer, nasopharyngeal cancer, and others), diagnosis (bioscopy screening tests, blood tests, dental diagnosis, imaging, and endoscopy), treatment (chemotherapy, radiation therapy, targeted therapy, surgery, and others), end use (hospitals, ambulatory surgical centers, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Head and Neck Cancer Diagnostic Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

  • 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
  • 3.2. Global Head and Neck Cancer Diagnostic Market Trends (2019-2024) and Forecast (2025-2031)
  • 3.3: Global Head and Neck Cancer Diagnostic Market by Type
    • 3.3.1: Laryngeal Cancer
    • 3.3.2: Pharyngeal Cancer
    • 3.3.3: Salivary Gland Cancer
    • 3.3.4: Lip & Oral Cavity Cancer
    • 3.3.5: Nasopharyngeal Cancer
    • 3.3.6: Others
  • 3.4: Global Head and Neck Cancer Diagnostic Market by Diagnosis
    • 3.4.1: Bioscopy Screening Tests
    • 3.4.2: Blood Tests
    • 3.4.3: Dental Diagnosis
    • 3.4.4: Imaging
    • 3.4.5: Endoscopy
  • 3.5: Global Head and Neck Cancer Diagnostic Market by Treatment
    • 3.5.1: Chemotherapy
    • 3.5.2: Radiation Therapy
    • 3.5.3: Targeted Therapy
    • 3.5.4: Surgery
    • 3.5.5: Others
  • 3.6: Global Head and Neck Cancer Diagnostic Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Diagnostic Centers
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

  • 4.1: Global Head and Neck Cancer Diagnostic Market by Region
  • 4.2: North American Head and Neck Cancer Diagnostic Market
    • 4.2.1: North American Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.2.2: North American Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.3: European Head and Neck Cancer Diagnostic Market
    • 4.3.1: European Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.3.2: European Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.4: APAC Head and Neck Cancer Diagnostic Market
    • 4.4.1: APAC Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.4.2: APAC Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others
  • 4.5: ROW Head and Neck Cancer Diagnostic Market
    • 4.5.1: ROW Market by Diagnosis : Bioscopy Screening Tests, Blood Tests, Dental Diagnosis, Imaging, and Endoscopy
    • 4.5.2: ROW Market by End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Type
    • 6.1.2: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Diagnosis
    • 6.1.3: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Treatment
    • 6.1.4: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by End Use
    • 6.1.5: Growth Opportunities for the Global Head and Neck Cancer Diagnostic Market by Region
  • 6.2: Emerging Trends in the Global Head and Neck Cancer Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Head and Neck Cancer Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Head and Neck Cancer Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GE Healthcare
  • 7.2: Philips
  • 7.3: Siemens Healthineers
  • 7.4: Merck
  • 7.5: Eli Lilly